The Rheumatoid Arthritis (RA) market is undergoing substantial growth driven by a combination of factors, including increasing prevalence of the disease, advancements in treatment options, and a growing emphasis on early diagnosis and personalized medicine. Rheumatoid arthritis, an autoimmune disorder causing chronic joint inflammation, has witnessed a paradigm shift in therapeutic approaches...